Compare Abbott Laboratories (ABT) vs Cincinnati Financial Corporation (CINF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Cincinnati Financial Corporation — how do they compare? Abbott Laboratories trades at $95.39 (market cap $166.94B), while Cincinnati Financial Corporation trades at $183.26 (market cap $29.25B). The key difference: Abbott Laboratories is far larger — about 5.7× Cincinnati Financial Corporation's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | CINF | |
|---|---|---|
Market Cap | $166.94B | $29.25B |
Sector | Health | Financials |
52-Week High | $136.62 | $192.03 |
52-Week Low | $82.57 | $145.80 |
Enterprise Value | $193.69B | $28.92B |
Dividend Yield | 2.63% | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Cincinnati Financial (CINF) trades at $189.06, down 1.55% on the day, but remains near its 52-week high. The stock shows strong fundamental performance with consistent earnings beats, a low P/E of 10.84, and robust profitability metrics including an 18.73% ROE. Recent technical indicators are mixed, with moving averages bullish but oscillators signaling overbought conditions. The company maintains a solid dividend track record, recently declaring a $0.94 dividend payable in July 2026.
CINF presents a compelling investment case supported by strong earnings growth, attractive valuation, and positive analyst sentiment, though near-term technical overbought signals and exposure to catastrophe losses pose risks. The consensus price target of $183.25 suggests limited upside from current levels, but long-term fundamentals remain sound.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Cincinnati Financial Corporation
Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →
